Biomedicine industry is one of Changzhou’s Key 10 Industrial chains as well as the strategic booming industry of Changzhou. On June 11^th local time, Changzhou Trade and Economic Delegation led by Mayor Fei Gaoyun arrived at New York City and inspected some US medical enterprises so as to seek cooperation.

American Bio-pharmaceutical industry is taking the lead in the world. Changzhou delegation visited US Kadmon Medical Group and ContraFect Bio-pharmaceutical company and talked with their high-profile leaders.

Kadmon Medical Group boasts a strong innovative new medicine R&D team. It has made great breakthrough in Gene therapy and immune system disease prevention recent years. Some new medication developed by the company have been used for clinical trials for cancer, diabetes and other complicated illnesses.

ContraFect Bio-pharmaceutical company has been listed on Nasdaq. It’s mainly specialized in researching and developing current human use of antibiotics alternatives and strives to produce landmark new drugs.

Mayor Fei Gaoyun said that the output value of Changzhou’s 146 new medicine enterprises reached 42.094 billion RMB in 2014, an increase of 11.1% over the period of previous year. A 10% increase is expected to be realized in 2015. Fei Gaoyun sincerely invited the high level leaders of these two companies to visit and inspect Changzhou so as to seek cooperative opportunities. Changzhou governments at all levels will try their best to supply with best service.